Anonymous User
Login / Registration

Gastroenterologie
a hepatologie

Gastroenterology and Hepatology

Gastroent Hepatol 2016; 70(4): 331–334. doi:10.14735/amgh2016csgh.info08.

Uncommon manifestation of cryptogenic hepatocellular carcinoma

Pavel Klvaňa Jr1, Marta Olbrechtová2, Martin Loveček Orcid.org  3, Barbara Budínská4, Petr Vítek5,6

+ Affiliation

Summary

Hepatocellular carcinoma is the sixth most common cancer worldwide; however, in our region, it is less frequent and occurs almost exclusively in patients with liver cirrhosis. About 10% of hepatocellular carcinomas are observed in patients with no history of chronic hepatitis or alcohol abuse and are classified as cryptogenic. Early stages of this disease are usually asymptomatic and are found accidentally or through screening examinations of patients with chronic liver disease. We present a case of a 65 year old men with no history of liver cirrhosis, who was admitted to our department of internal medicine complaining of epigastric pain caused by spontaneous hemorrhage of a cryptogenic hepatocellular carcinoma in the right lobe of his liver.

Keywords

hepatocellular carcinoma, spontaneous hemorrhage, subcapsular liver hematoma

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Literature

1. Taura N, Ichikawa T, Miyaaki H et al. Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma. Med Sci Monit 2013; 19 (1): 742–750. doi: 10.12659/MSM.889361.
2. International Agency for Research on Cancer. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. [online]. Available from: http: //globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
3. Zvolský M. Zhoubné nádory v roce 2011. Ústav zdravotnických informací a statistiky ČR. [online]. Dostupné z: www.uzis.cz/rychle-informace/zhoubne-nadory-roce-2011.
4. Hsu CY, Lee YH, Liu PH et al. Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model. PLoS One 2014; 9 (2): e89373. doi: 10.1371/journal.pone.0089373.
5. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transplant 2004; 10 (2 Suppl 1): S115–S120.
6. Brůha R, Šperl J, Urbánek P et al. Doporučený postup pro léčbu a diagnostiku hepatocelulárního karcinomu. Gastroent Hepatol 2012; 66 (2): 83–92.
7. Blonski W, Kotlyar DS, Forde KA. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 2010; 16 (29): 3603–3615.
8. Ndzengue A, Hammoudeh F, Brutus P  et al. An obscure case of hepatic subcapsular hematoma. Case Rep Gastroenterol 2011; 5 (1): 223–226. doi: 10.1159/000326998.
9. Chen ZY, Qi QH, Dong ZL. Etiology and management of hemmorrhage in spontaneous liver rupture: a report of 70 cases. World J Gastroenterol 2002; 8 (6): 1063–1066.
10. El Youssoufi S, Nsiri A, Salmi S. Liver rupture in peripartum: about 8 cases. J Gynecol Obstet Biol Reprod (Paris) 2007; 36 (1): 57–61.

Credited self-teaching test